Last reviewed · How we verify
beta carotene from Dunaliella algae — Competitive Intelligence Brief
phase 3
Nutrition, Dermatology, Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
beta carotene from Dunaliella algae (beta carotene from Dunaliella algae) — Bnai Zion Medical Center. Beta carotene from Dunaliella algae is converted to vitamin A in the body, which is essential for maintaining healthy vision, immune function, and skin health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| beta carotene from Dunaliella algae TARGET | beta carotene from Dunaliella algae | Bnai Zion Medical Center | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- beta carotene from Dunaliella algae CI watch — RSS
- beta carotene from Dunaliella algae CI watch — Atom
- beta carotene from Dunaliella algae CI watch — JSON
- beta carotene from Dunaliella algae alone — RSS
Cite this brief
Drug Landscape (2026). beta carotene from Dunaliella algae — Competitive Intelligence Brief. https://druglandscape.com/ci/beta-carotene-from-dunaliella-algae. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab